3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Phase 2
1
Status
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Cholangiocarcinoma
3
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Papillomavirus Infections
1
Oncogenic osteomalacia
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Melanoma
1
Hypophosphatemia
1
Hematologic Neoplasms
1
Glioblastoma
1
Acrocephalosyndactylia
1
Interventions
pemigatinib
5
Rogaratinib
2
pembrolizumab
1
lenvatinib
1
infigratinib
1
erdafitinib
1
brivanib
1
Rabeprazole
1
Irinotecan
1
INCB 54828-101
1
Gemcitabine
1
E-3810
1
Drug Combinations
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Acrocephalosyndactylia
×
infigratinib
×
Clear all
NCT05019794
2022-06-27
FGFR
LianBio LLC
Phase 2
Unknown
80 enrolled